BLOG

15 04 2023 09 12 48 Navneet Singh Avsar

नवनीत सिंह: एक साहसी कदम से करोड़ों का सफर

कोशिश करने वालों की हार नहीं होती। सोहनलाल द्विवेदी की यह पंक्तियाँ बिहार के नवनीत कुमार सिंह पर बिल्कुल सटीक बैठती हैं। नवनीत ने नौकरी छोड़कर अपनी खुद की कंपनी खोलने का साहसिक निर्णय लिया, जो आज 520 करोड़ रुपये के टर्नओवर वाली कंपनी बन चुकी है। यह कहानी नवनीत की उस यात्रा की है…

Read More
Img 20240914 Wa0001

How to Make Your Workout Most Effective?

How to Make Your Workout Most Effective? Working out effectively isn’t just about spending hours in the gym. It’s about exercising with purpose, planning, and consistency. From setting clear goals to ensuring proper nutrition and tracking progress, there are several key elements that can help make your workout routine more efficient and rewarding. In this…

Read More
Img 20240913 Wa0029

Devinderjeet Kaur: From Struggle to Strength – A Fitness Transformation Story

Devinderjeet Kaur: From Struggle to Strength – A Fitness Transformation Story Keywords: fitness journey, weight loss transformation, health and wellness, INFS certified, postpartum weight loss, C-section recovery, marathon runner, balanced nutrition Devinderjeet Kaur, a mother of a 14-year-old girl, exemplifies the power of resilience and determination. After her daughter’s birth via C-section, Devinderjeet’s life took…

Read More
Fb Img 1726222284184

Injury Prevention, Rehabilitation, and Resuming Workouts: A Comprehensive Guide

Injury Prevention, Rehabilitation, and Resuming Workouts: A Comprehensive Guide By Ashima Kapoor, Fittr Coach Injuries can be a frustrating and disheartening part of any fitness journey, whether they occur in the gym, at home, or during sports activities. As a Fittr Coach, I understand how essential it is to manage these setbacks effectively and get…

Read More
Download (2)

GSK Advances mRNA Flu Vaccine to Late-Stage Trials Following Positive Mid-Stage Results

GSK Advances mRNA Flu Vaccine to Late-Stage Trials Following Positive Mid-Stage Results British pharmaceutical giant GSK has announced promising results from a mid-stage trial of its mRNA-based seasonal flu vaccine, marking a key milestone towards late-stage clinical development. The trial demonstrated that the new vaccine candidate elicited strong immune responses against both influenza A and…

Read More